Compare Income Statements and Balance Sheets of Competitors a. Following are selected income statements from two pharmaceutical companies, Pfizer and Dr. Reddy's, for their respective 2018 fiscal years. Express each income statement amount as a percentage of sales. Note: Round percentage to one decimal point (for example, round 18.566% to 18.6%). Income Statement ($ millions) Sales Pfizer Dr. Reddy's $46,136 0% $1,876 0% Cost of goods sold 11,248 096 1,009 096 Gross profit 34,888 096 867 096 Total expenses Net income 26,841 $8,047 09 096 878 $(11) 096 096 b. Following are selected balance sheets from two pharmaceutical companies, Pfizer and Dr. Reddy's, for their respective 2018 fiscal years. Express each balance sheet amount as a percentage of total assets. Note: Round percentage to one decimal point (for example, round 18.566% to 18.6%). Balance Sheet ($ millions) Pfizer Dr. Reddy's Current assets $42,936 0% $1,448 096 Long-term assets 109,496 096 1,781 Total assets $152,432 096 $3,229 Current liabilities $27,398 096 $920 Long-term liabilities 54,873 096 390 Total liabilities 82,271 096 1,310 Stockholders' equity 70,161 096 1,919 Total liabilities and equity $152,432 096 $3,229 ៖៖៖៖៖៖៖
Compare Income Statements and Balance Sheets of Competitors a. Following are selected income statements from two pharmaceutical companies, Pfizer and Dr. Reddy's, for their respective 2018 fiscal years. Express each income statement amount as a percentage of sales. Note: Round percentage to one decimal point (for example, round 18.566% to 18.6%). Income Statement ($ millions) Sales Pfizer Dr. Reddy's $46,136 0% $1,876 0% Cost of goods sold 11,248 096 1,009 096 Gross profit 34,888 096 867 096 Total expenses Net income 26,841 $8,047 09 096 878 $(11) 096 096 b. Following are selected balance sheets from two pharmaceutical companies, Pfizer and Dr. Reddy's, for their respective 2018 fiscal years. Express each balance sheet amount as a percentage of total assets. Note: Round percentage to one decimal point (for example, round 18.566% to 18.6%). Balance Sheet ($ millions) Pfizer Dr. Reddy's Current assets $42,936 0% $1,448 096 Long-term assets 109,496 096 1,781 Total assets $152,432 096 $3,229 Current liabilities $27,398 096 $920 Long-term liabilities 54,873 096 390 Total liabilities 82,271 096 1,310 Stockholders' equity 70,161 096 1,919 Total liabilities and equity $152,432 096 $3,229 ៖៖៖៖៖៖៖
Managerial Accounting: The Cornerstone of Business Decision-Making
7th Edition
ISBN:9781337115773
Author:Maryanne M. Mowen, Don R. Hansen, Dan L. Heitger
Publisher:Maryanne M. Mowen, Don R. Hansen, Dan L. Heitger
Chapter15: Financial Statement Analysis
Section: Chapter Questions
Problem 38E: Sundahl Companys income statements for the past 2 years are as follows: Refer to the information for...
Related questions
Question
Transcribed Image Text:Compare Income Statements and Balance Sheets of Competitors
a. Following are selected income statements from two pharmaceutical companies, Pfizer and Dr. Reddy's, for their respective 2018 fiscal years. Express each income statement
amount as a percentage of sales.
Note: Round percentage to one decimal point (for example, round 18.566% to 18.6%).
Income Statement ($ millions)
Sales
Pfizer
Dr. Reddy's
$46,136
0% $1,876
09
Cost of goods sold
11,248
0% 1,009
0%
Gross profit
34,888
0%
867
0%
Total expenses
Net income
26,841
$8,047
0%
0%
878
$(11)
0%
0%
b. Following are selected balance sheets from two pharmaceutical companies, Pfizer and Dr. Reddy's, for their respective 2018 fiscal years. Express each balance sheet amount as a
percentage of total assets.
Note: Round percentage to one decimal point (for example, round 18.566% to 18.6%).
Balance Sheet ($ millions)
Pfizer
Dr. Reddy's
Current assets
$42,936
0% $1,448
0%
Long-term assets
Total assets
109,496
$152,432
0% 1,781
096
0% $3,229
09
Current liabilities
$27,398
0% $920
0%
Long-term liabilities
54,873
0%
390
0%
Total liabilities
82,271
0% 1,310
0%
Stockholders' equity
70,161
0% 1,919
0 %
Total liabilities and equity
$152,432
0% $3,229
096
Expert Solution
This question has been solved!
Explore an expertly crafted, step-by-step solution for a thorough understanding of key concepts.
This is a popular solution!
Trending now
This is a popular solution!
Step by step
Solved in 4 steps
Knowledge Booster
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, accounting and related others by exploring similar questions and additional content below.Recommended textbooks for you
Managerial Accounting: The Cornerstone of Busines…
Accounting
ISBN:
9781337115773
Author:
Maryanne M. Mowen, Don R. Hansen, Dan L. Heitger
Publisher:
Cengage Learning
Financial Accounting: The Impact on Decision Make…
Accounting
ISBN:
9781305654174
Author:
Gary A. Porter, Curtis L. Norton
Publisher:
Cengage Learning
Managerial Accounting
Accounting
ISBN:
9781337912020
Author:
Carl Warren, Ph.d. Cma William B. Tayler
Publisher:
South-Western College Pub
Managerial Accounting: The Cornerstone of Busines…
Accounting
ISBN:
9781337115773
Author:
Maryanne M. Mowen, Don R. Hansen, Dan L. Heitger
Publisher:
Cengage Learning
Financial Accounting: The Impact on Decision Make…
Accounting
ISBN:
9781305654174
Author:
Gary A. Porter, Curtis L. Norton
Publisher:
Cengage Learning
Managerial Accounting
Accounting
ISBN:
9781337912020
Author:
Carl Warren, Ph.d. Cma William B. Tayler
Publisher:
South-Western College Pub
Financial And Managerial Accounting
Accounting
ISBN:
9781337902663
Author:
WARREN, Carl S.
Publisher:
Cengage Learning,
Financial Accounting
Accounting
ISBN:
9781337272124
Author:
Carl Warren, James M. Reeve, Jonathan Duchac
Publisher:
Cengage Learning
Financial Accounting
Accounting
ISBN:
9781305088436
Author:
Carl Warren, Jim Reeve, Jonathan Duchac
Publisher:
Cengage Learning